Background: Microvascular complications are long-term complications that affect small blood vessels, usually developed in diabetes, and are primary causes of end-stage renal disease, several painful neuropathies, and blindness. Thus, this study aimed to determine diabetic microvascular complications and factors associated with them among patients with type 2 diabetes. Methods: An institution-based cross-sectional study was conducted among type 2 diabetes patients.
The presence of at least one diabetic microvascular complications diagnosed by physicians and found on the record was considered to have microvascular complications.
The data was collected by reviewing the medical records of T2DM patients who were on follow-up from January 1, , to December 31, The collected data was entered into EpiData version 3. Results: Patients with type 2 diabetes mellitus had a prevalence of diabetic microvascular complications of Diabetic neuropathy was the highest Increasing age, poor glycemic control, hypertension comorbidity, anemia, positive proteinuria, a longer duration of type 2 diabetes mellitus, and hypercholesterolemia were significantly associated factors with diabetic microvascular complications.
Conclusion: Diabetic microvascular complications were highly prevalent. Therefore, the study suggests that interventional strategies should be taken for poor glycemic control, hypertension comorbidity, anemia, positive proteinuria, and hypercholesterolemia to control the development of diabetic microvascular complications in patients with type 2 diabetes.
Diabetes mellitus DM is a chronic metabolic disease characterized by elevated levels of blood sugar, which over time leads to serious damage to the heart, blood vessels, eyes, kidneys, and nerves 1. It is found worldwide in every population in all regions, and its prevalence is continuously increasing 2. According to the International Diabetes Federation, in , the prevalence of people living with diabetes was estimated at million, or Globally, the rising tide of physical inactivity, energy-dense diets, and obesity has resulted in an unprecedented increase in the number of patients with T2DM 6.
